Skip to main content
. 2020 Oct 21;17:51. doi: 10.1186/s12970-020-00379-0

Table 6.

Course of cardiorespiratory variables during the recovery phase

Variable Group Trial Time (minutes’ seconds”) Cumulative AUC Intra-groupp-value Inter-group · Time−1
000 130 300 430
Lactate (mmol/L) DHA Baseline 12.0±3.2 12.4±1.8 11.8±1.7 11.3±1.4 880.6±100.4 } p = 0.841 } p = 0.694
Post 11.2±1.9 12.1±1.9 12.0±2.0 11.2±2.3 874.5±141.6
PLA Baseline 11.4±1.7 12.2±2.0 12.0±1.7 11.5±2.1 908.1±157.2 } p = 0.718
Post 11.3±2.4 12.4±1.6 12.2±1.8 12.1±1.9 918.4±127.0
VO2 (ml/min) DHA Baseline 3662±425 2122±451 1767±363 1556±285 584,825±91,516 } p = 0.034* } p = 0.136
Post 3662±549 2248±421 1960±365 1750±374 622,230±97,050
PLA Baseline 3629±403 2154±336 1791±287 1654±282 592,765±75,399 } p = 0.920
Post 3600±432 2142±427 1800±407 1726±399 594,396±100,112
HR (bpm) DHA Baseline 184±9 158±12 158±12 141±12 41,010±2,778 } p = 0.001* } p = 0.005*
Post 182±9 151±12 130±11 122±13 38,955±2,719
PLA Baseline 181±10 155±13 137±12 137±12 40,259±3,135 } p = 0.024*
Post 180±10 152±12 134±11 128±9 39,535±2,682

Values are presented as mean ± standard deviation (SD). Intra-group and inter-group analysis corresponds to the cumulative area under the curve (AUC) * p <0.05